Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 219,563,328
  • Shares Outstanding, K 1,771,529
  • Annual Sales, $ 34,608 M
  • Annual Income, $ 4,495 M
  • 60-Month Beta 0.71
  • Price/Sales 6.22
  • Price/Cash Flow 21.80
  • Price/Book 6.61
Trade ABT with:

Options Overview

Details
  • Implied Volatility 18.86%
  • Historical Volatility 19.22%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 42.81% on 08/27/20
  • IV Low 18.86% on 04/16/21
  • Put/Call Vol Ratio 0.43
  • Today's Volume 13,488
  • Volume Avg (30-Day) 8,218
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 152,376
  • Open Int (30-Day) 100,734

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 1.33
  • Number of Estimates 9
  • High Estimate 1.43
  • Low Estimate 1.26
  • Prior Year 0.65
  • Growth Rate Est. (year over year) +104.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.92 +6.36%
on 03/17/21
124.68 -0.26%
on 04/15/21
+6.13 (+5.19%)
since 03/16/21
3-Month
110.26 +12.78%
on 01/21/21
128.54 -3.26%
on 02/12/21
+13.05 (+11.73%)
since 01/15/21
52-Week
86.16 +44.32%
on 06/25/20
128.54 -3.26%
on 02/12/21
+28.35 (+29.53%)
since 04/16/20

Most Recent Stories

More News
Senseonics vs. Abbott Laboratories: Which Diabetes Stock is a Better Buy?

Type 1 and type 2 diabetes cases are still rising and demand for diabetes care devices is growing quickly in response. Against that backdrop, we think diabetes care device makers Senseonics Holdings (SENS)...

ABT : 124.35 (+0.33%)
SENS : 1.8900 (-4.55%)
5 MedTech Outperformers With Nearly 40% or More Gain in 2021

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

OMI : 37.57 (-0.50%)
ABT : 124.35 (+0.33%)
HSIC : 71.17 (+0.38%)
PEN : 287.39 (+0.37%)
NDRA : 2.18 (-1.80%)
AMEH : 27.04 (-0.33%)
NTUS : 28.22 (+0.93%)
Acute Otitis Media Treatment Market Size With CAGR, Scenario, Outlook, Trend and Forecast 2020 - 2027 By Ameco Research

pune, India, Fri, 16 Apr 2021 04:37:09 / Comserve Inc. / -- The study talks about the growth rate, market share as well as the recent developments in the Acute Otitis Media Treatment Market industry worldwide....

ABT : 124.35 (+0.33%)
BAYRY : 16.2200 (+2.21%)
LLY : 189.25 (+1.79%)
GSK : 37.75 (+0.16%)
MFAC : 14.76 (-0.74%)
NVS : 88.02 (+0.94%)
PDP.VN : 0.300 (+1.69%)
PFE : 38.57 (+2.58%)
Varicella Zoster Infection Treatment Market Research Report by Trends, by Type, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19

The is segmented on the lines of its drug type, route of administration and regional. Basis of drug type is segmented into Acyclovir, Valacyclovir and Famciclovir. Based on route of administration it...

ABT : 124.35 (+0.33%)
GSK : 37.75 (+0.16%)
NVS : 88.02 (+0.94%)
PFE : 38.57 (+2.58%)
TEVA : 10.75 (-0.74%)
VRX.TO : 30.80 (-3.33%)
Dry Eye Syndrome Treatment Market 2021 SWOT Analysis (PDF Report) & Key Business Strategies by Leading Players |Novartis AG, Allergan, Alcon

The studies on worldwide Dry Eye Syndrome Treatment market evaluate the capabilities, organizations, infrastructure, determines measures to attain success. Due to an, the study at permits the traders to...

ABT : 124.35 (+0.33%)
AKRX : 0.0900 (-51.01%)
AGN : 193.02 (+0.02%)
NVS : 88.02 (+0.94%)
VRX.TO : 30.80 (-3.33%)
The Zacks Analyst Blog Highlights: Abbott, Salesforce, BHP Group, Danaher and Zoom Video

The Zacks Analyst Blog Highlights: Abbott, Salesforce, BHP Group, Danaher and Zoom Video

BHP : 73.75 (-0.43%)
ABT : 124.35 (+0.33%)
CRM : 231.91 (-0.47%)
DHR : 243.06 (+0.19%)
ZM : 329.95 (-0.73%)
Diabetic Retinopathy Market Size, Trends and Growth Analysis with Leading Players – Novartis AG, Valeant Pharmaceuticals International Inc., Abbott Laboratories Ltd.

The global was valued at USD 7.39 billion in 2018 and is expected to reach USD 13.04 billion by 2026, at a CAGR of 7.3%. Diabetic retinopathy is a diabetes obstacle that affects eyes. It’s caused by...

ABT : 124.35 (+0.33%)
ALIM : 9.80 (-4.95%)
AMPE : 1.5700 (unch)
NVS : 88.02 (+0.94%)
PRXL : 88.08 (-0.02%)
PFE : 38.57 (+2.58%)
REGN : 502.60 (+1.61%)
VRX.TO : 30.80 (-3.33%)
Top Stock Reports for Abbott, salesforce & BHP

Top Stock Reports for Abbott, salesforce & BHP

ZM : 329.95 (-0.73%)
DHR : 243.06 (+0.19%)
CRM : 231.91 (-0.47%)
BHP : 73.75 (-0.43%)
AMGN : 255.71 (+0.23%)
ABT : 124.35 (+0.33%)
Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed at $123.01 in the latest trading session, marking a +1.63% move from the prior day.

ABT : 124.35 (+0.33%)
Abbott (ABT) Earnings Expected to Grow: Should You Buy?

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ABT : 124.35 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

3rd Resistance Point 127.89
2nd Resistance Point 126.29
1st Resistance Point 125.11
Last Price 124.35
1st Support Level 122.33
2nd Support Level 120.73
3rd Support Level 119.55

See More

52-Week High 128.54
Last Price 124.35
Fibonacci 61.8% 112.35
Fibonacci 50% 107.35
Fibonacci 38.2% 102.35
52-Week Low 86.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar